Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Stock
Equities
603707
CNE100002WP3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.95 CNY | +0.87% | +1.90% | -7.00% |
May. 13 | NKFPharma's Unit Gets FDA's Nod to Market Eptifibatide Injection in US | MT |
May. 01 | NKFPharma Gets Nod to Register New Cancer Treatment | MT |
Sales 2024 * | 4.37B 606M | Sales 2025 * | 6.07B 841M | Capitalization | 22.48B 3.11B |
---|---|---|---|---|---|
Net income 2024 * | 923M 128M | Net income 2025 * | 1.54B 214M | EV / Sales 2024 * | 5.14 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.7 x |
P/E ratio 2024 * |
24.5
x | P/E ratio 2025 * |
14.6
x | Employees | 1,451 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.7% |
1 day | +0.87% | ||
1 week | +1.90% | ||
Current month | +1.82% | ||
1 month | +9.67% | ||
3 months | +0.29% | ||
6 months | +6.16% | ||
Current year | -7.00% |
Managers | Title | Age | Since |
---|---|---|---|
Yong Qun Tang
CEO | Chief Executive Officer | 49 | 03-12-31 |
Xiao Jie Qian
DFI | Director of Finance/CFO | 44 | 10-12-31 |
Xi Wei Huang
BRD | Director/Board Member | 54 | 11-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xi Wei Huang
BRD | Director/Board Member | 54 | 11-03-31 |
Ping Shi
BRD | Director/Board Member | 62 | 19-05-15 |
Yong Qun Tang
CEO | Chief Executive Officer | 49 | 03-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.49% | 2 M€ | -11.89% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 13.95 | +0.87% | 4,122,837 |
24-05-13 | 13.83 | -0.50% | 5,136,578 |
24-05-10 | 13.9 | +0.43% | 5,182,906 |
24-05-09 | 13.84 | +2.52% | 6,426,405 |
24-05-08 | 13.5 | -1.39% | 4,936,157 |
End-of-day quote Shanghai S.E., May 13, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.00% | 3.11B | |
+30.55% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+14.77% | 239B | |
+9.82% | 210B | |
-7.48% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- 603707 Stock